512 Targeting HLA-E positive cancers with a novel NKG2A/C switch receptor

• Michel Sadelain,
• Karl-Johan Malmberg,
• Jorge Mansilla-Soto,
• Michelle Saetersmoen,
• Quirin Hammer,
• Ivan Kotchetkov,
• Lamberto Torralba-Raga,
• Silje Zandstra-Krokeide

Affiliations

Michel Sadelain

2Memorial Sloan Kettering Cancer Center, New York, NY, USA

Karl-Johan Malmberg

1Oslo University Hospital, Oslo, Norway

Jorge Mansilla-Soto

2Memorial Sloan Kettering Cancer Center, New York, NY, USA

Michelle Saetersmoen

1Oslo University Hospital, Oslo, Norway

Quirin Hammer

3Center for Infectious Medicine, Karolinska Institutet, Stockholm, Sweden

Ivan Kotchetkov

2Memorial Sloan Kettering Cancer Center, New York, NY, USA

Lamberto Torralba-Raga

1Oslo University Hospital, Oslo, Norway

Silje Zandstra-Krokeide

1Oslo University Hospital, Oslo, Norway